4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Seer, Inc. (SEER) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 124 employees. Its market capitalization is roughly $112 million. In the fiscal year ended 2025-12-31, SEER reported $16M in revenue and ($74M) in net income.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Interactive charts & full statements → Open the SEER valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $16M | $14M | $15M | $15M | — |
| Gross Profit | $8M | $7M | $7M | $6M | — |
| Operating Income (EBIT) | ($78M) | ($100M) | ($104M) | ($97M) | — |
| Net Income | ($74M) | ($87M) | ($86M) | ($93M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $3M | $4M | $4M | $4M | $4M |
| Gross Profit | $1M | $2M | $2M | $2M | $2M |
| Operating Income (EBIT) | ($17M) | ($17M) | ($19M) | ($20M) | ($21M) |
| Net Income | ($17M) | ($16M) | ($18M) | ($19M) | ($20M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $296M | $367M | $436M | $488M | — |
| Total Liabilities | $37M | $39M | $39M | $41M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SEER viewer.
About TickerBase · Data methodology & sources